Triastek belongs to the pharmaceutical industry and it develops medicines using 3D printing technology. It facilitates the research, development and manufacturing of pharmaceutical products, specifically layered medicines for the controlled treatment of rheumatoid arthritis, cardiovascular diseases, pulmonary hypertension, ulcerative colitis and more. It primarily serves the healthcare and pharmaceutical industries. The company was founded in 2015 and is based in Nanjing, China.